Beam Therapeutics Inc. BEAM
4 trading plans running, 17 Form 144 notices for $13.4M
10-Q, 10-K and Form 144What BEAM's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Nov 7, 2024 to Sep 17, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in |
|---|---|---|---|
| Bethany Cavanagh Senior Vice President, Finance |
Adopted 10b5-1 plan | Sep 17, 2026 | 10-Q Nov 3, 2026 |
| John Evans Chief Executive Officer |
Adopted 10b5-1 plan | Jun 16, 2026 | 10-Q Aug 4, 2026 |
| Amy Simon Chief Medical Officer |
Adopted 10b5-1 plan | Mar 27, 2026 | 10-Q May 7, 2026 |
| Christine Bellon Chief Legal Officer |
Adopted 10b5-1 plan | Mar 27, 2026 | 10-Q May 7, 2026 |
| Giuseppe Ciaramella President |
Adopted 10b5-1 plan | Sep 30, 2025 | 10-Q Nov 4, 2025 |
| Bethany Cavanagh Senior Vice President, Finance |
Adopted 10b5-1 plan | Sep 19, 2025 | 10-Q Nov 4, 2025 |
| Christine Bellon Chief Legal Officer |
Adopted 10b5-1 plan | Sep 16, 2025 | 10-Q Nov 4, 2025 |
| Sravan K. Emany Chief Financial Officer |
Adopted 10b5-1 plan | Aug 11, 2025 | 10-K Feb 24, 2026 |
| John Evans Chief Executive Officer |
Adopted 10b5-1 plan | May 16, 2025 | 10-Q Aug 5, 2025 |
| Amy Simon Chief Medical Officer |
Adopted 10b5-1 plan | Nov 7, 2024 | 10-K Feb 25, 2025 |
| Giuseppe Ciaramella President |
Adopted 10b5-1 plan | Sep 26, 2024 | 10-Q Nov 5, 2024 |
| Christine Bellon Chief Legal Officer |
Adopted 10b5-1 plan | Sep 20, 2024 | 10-Q Nov 5, 2024 |
| Bethany Cavanagh Senior Vice President, Finance |
Adopted 10b5-1 plan | Aug 9, 2024 | 10-Q Nov 5, 2024 |
| Giuseppe Ciaramella President |
Adopted 10b5-1 plan | Jun 28, 2024 | 10-Q Aug 6, 2024 |
| John Evans Chief Executive Officer |
Adopted 10b5-1 plan | Jun 14, 2024 | 10-Q Aug 6, 2024 |
| Giuseppe Ciaramella President |
Adopted 10b5-1 plan | Dec 20, 2023 | 10-K Feb 27, 2024 |
| Christine Bellon Chief Legal Officer |
Adopted 10b5-1 plan | Dec 12, 2023 | 10-K Feb 27, 2024 |
| Terry-Ann Burrell Chief Financial Officer |
Adopted 10b5-1 plan | Dec 8, 2023 | 10-K Feb 27, 2024 |
Show the other 10 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 10, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Oct 16, 2026 | JOHN M EVANS Officer, Director |
25,000 | $600K |
| Oct 15, 2026 | JOHN M EVANS Officer, Director |
25,000 | $589K |
| Jul 27, 2026 | AMY SIMON Officer |
16,677 | $429K |
| Jun 30, 2026 | JOHN M EVANS Officer, Director |
25,000 | $858K |
| Jun 29, 2026 | JOHN M EVANS Officer, Director |
25,000 | $887K |
| Apr 14, 2026 | CAROLE HO Director |
87,784 | $2.7M |
| Mar 31, 2026 | JOHN M EVANS Officer, Director |
25,000 | $569K |
| Mar 31, 2026 | CHRISTINE BELLON Officer |
20,000 | $438K |
| Mar 31, 2026 | GIUSEPPE CIARAMELLA Officer |
26,250 | $575K |
| Mar 31, 2026 | AMY SIMON Officer |
20,000 | $438K |
| Mar 31, 2026 | JOHN M. EVANS Officer, Director |
66,874 | $1.5M |
| Mar 30, 2026 | JOHN M EVANS Officer, Director |
25,000 | $559K |
| Feb 24, 2026 | GIUSEPPE CIARAMELLA Officer |
35,000 | $1.1M |
| Jan 30, 2026 | JOHN M EVANS Officer, Director |
25,000 | $709K |
| Jan 29, 2026 | JOHN M EVANS Officer, Director |
25,000 | $735K |
| Jan 22, 2026 | CHRISTINE BELLON Officer |
1,371 | $47K |
| Jan 15, 2026 | CHRISTINE BELLON Officer |
18,629 | $645K |
Show the other 9 notices
From the Form 144 XML filed with the SEC, since Jan 15, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/BEAM/export.csv") into a cell.